CytoDyn (CYDY) Net Cash Flow (2010 - 2026)
CytoDyn's (CYDY) quarterly Net Cash Flow came in at $10.7 million in Q1 2026, up 316.27% YoY from $2.6 million in Q1 2025, and up 345.36% on a QoQ basis from -$4.4 million in Q4 2025.
CytoDyn (CYDY) Net Cash Flow (2010 - 2026) Analysis & Trends
CytoDyn (CYDY) has 17 years of Net Cash Flow data on file, last reported at $10.7 million in Q1 2026.
- Quarterly Net Cash Flow rose 316.27% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$745000.0 (down 108.89% YoY) and the FY2025 annual result came in at $2.1 million, up 172.72% from the prior year.
- Net Cash Flow advanced to $10.7 million in Q1 2026, from -$4.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $15.1 million in Q3 2024 to a low of -$6.5 million in Q1 2022.
- A 5-year average of $397058.8 and a median of -$1.8 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow soared 3273.74% — and 2025, when it tumbled 479.91%.
- Tracing CYDY's Net Cash Flow over 5 years: stood at -$2.1 million in 2022, then advanced by 10.85% to -$1.8 million in 2023, then plunged by 94.05% to -$3.6 million in 2024, then slipped by 21.31% to -$4.4 million in 2025, then soared by 345.36% to $10.7 million in 2026.
- The last three Net Cash Flow figures came in at $10.7 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 10.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.67 Mn |
| Feb 28, 2026 | 10.67 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Nov 30, 2025 | -4.35 Mn |
| Aug 31, 2025 | -2.57 Mn |
| Aug 31, 2025 | -2.57 Mn |
| May 31, 2025 | -4.50 Mn |
| May 31, 2025 | -4.50 Mn |
| Feb 28, 2025 | -4.94 Mn |
| Feb 28, 2025 | -4.94 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Nov 30, 2024 | -3.59 Mn |
| Aug 31, 2024 | 15.11 Mn |
| Aug 31, 2024 | 15.11 Mn |
| May 31, 2024 | 1.79 Mn |
| May 31, 2024 | 1.79 Mn |
| Feb 29, 2024 | 1.30 Mn |
| Feb 29, 2024 | 1.30 Mn |
| Nov 30, 2023 | -1.85 Mn |
| Nov 30, 2023 | -1.85 Mn |